IGC Pharma, Inc 8-K 12-15-25 - IGC Pharma, INC.

SEC

Filings

December 15, 2025

IGC Pharma, Inc 8-K 12-15-25

IGC Pharma, Inc. IGC on NYSE

Related Posts

IGC Pharma, Inc. 424B5 01-06-26

January 6, 2026

IGC Pharma, Inc 8-K 01-06-26

January 6, 2026

IGC Pharma, Inc 8-K 01-02-26

January 2, 2026

CEO Update

IGC Pharma to Participate in Fireside Chat with Ascendiant Capital Markets

February 12, 2026

IGC Pharma Announces Equity Research Update by Alliance Global Partners

February 10, 2026